117 related articles for article (PubMed ID: 33624357)
1. In silico prediction of T-cell and B-cell epitopes of human papillomavirus type 16 L1 protein.
Mahmoudvand S; Shokri S; Makvandi M; Taherkhani R; Rashno M; Jalilian FA; Angali KA
Biotechnol Appl Biochem; 2022 Apr; 69(2):514-525. PubMed ID: 33624357
[TBL] [Abstract][Full Text] [Related]
2. [Prediction of B cell epitopes of human papillomavirus type 16 L1 protein].
Wang A; Jiang M; Li N; Zhang G; Qi Y; Liu Y; Xi Y; Zhou J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Apr; 32(4):442-5. PubMed ID: 27053606
[TBL] [Abstract][Full Text] [Related]
3. Identification of human papillomavirus-16 E6 variation in cervical cancer and their impact on T and B cell epitopes.
Kumar A; Hussain S; Yadav IS; Gissmann L; Natarajan K; Das BC; Bharadwaj M
J Virol Methods; 2015 Jun; 218():51-8. PubMed ID: 25800725
[TBL] [Abstract][Full Text] [Related]
4. In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccine.
Namvar A; Bolhassani A; Javadi G; Noormohammadi Z
Sci Rep; 2019 Oct; 9(1):15225. PubMed ID: 31645650
[TBL] [Abstract][Full Text] [Related]
5. Designing of Epitope-Focused Vaccine by Targeting E6 and E7 Conserved Protein Sequences: An Immuno-Informatics Approach in Human Papillomavirus 58 Isolates.
Sabah SN; Gazi MA; Sthity RA; Husain AB; Quyyum SA; Rahman M; Islam MR
Interdiscip Sci; 2018 Jun; 10(2):251-260. PubMed ID: 27640170
[TBL] [Abstract][Full Text] [Related]
6. The U4 Antibody Epitope on Human Papillomavirus 16 Identified by Cryo-electron Microscopy.
Guan J; Bywaters SM; Brendle SA; Lee H; Ashley RE; Christensen ND; Hafenstein S
J Virol; 2015 Dec; 89(23):12108-17. PubMed ID: 26401038
[TBL] [Abstract][Full Text] [Related]
7. Identification of the impact on T- and B- cell epitopes of human papillomavirus type-16 E6 and E7 variant in Southwest China.
Chenzhang Y; Wen Q; Ding X; Cao M; Chen Z; Mu X; Wang T
Immunol Lett; 2017 Jan; 181():26-30. PubMed ID: 27693214
[TBL] [Abstract][Full Text] [Related]
8. Dissection of Capsid Protein HPV 52 to Rationalize Vaccine Designs Using Computational Approaches Immunoinformatics and Molecular Docking.
Firdaus MER; Mustopa AZ; Triratna L; Syahputra G; Nurfatwa M
Asian Pac J Cancer Prev; 2022 Jul; 23(7):2243-2253. PubMed ID: 35901328
[TBL] [Abstract][Full Text] [Related]
9. A novel HPV prophylactic peptide vaccine, designed by immunoinformatics and structural vaccinology approaches.
Negahdaripour M; Eslami M; Nezafat N; Hajighahramani N; Ghoshoon MB; Shoolian E; Dehshahri A; Erfani N; Morowvat MH; Ghasemi Y
Infect Genet Evol; 2017 Oct; 54():402-416. PubMed ID: 28780192
[TBL] [Abstract][Full Text] [Related]
10. Genetic variability in minor capsid protein (L2 gene) of human papillomavirus type 16 among Indian women.
Mane A; Limaye S; Patil L; Kulkarni-Kale U
Med Microbiol Immunol; 2022 Jun; 211(2-3):153-160. PubMed ID: 35552511
[TBL] [Abstract][Full Text] [Related]
11. The polymorphism analysis and epitope predicted of Alphapapillomavirus 9 E6 in Sichuan, China.
He J; Li Q; Ma S; Li T; Chen Y; Liu Y; Cui Y; Peng J; Shi Y; Wei X; Ding X
Virol J; 2022 Jan; 19(1):14. PubMed ID: 35057815
[TBL] [Abstract][Full Text] [Related]
12. Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.
Christensen ND; Cladel NM; Reed CA; Budgeon LR; Embers ME; Skulsky DM; McClements WL; Ludmerer SW; Jansen KU
Virology; 2001 Dec; 291(2):324-34. PubMed ID: 11878901
[TBL] [Abstract][Full Text] [Related]
13. Memory T cells specific for novel human papillomavirus type 16 (HPV16) E6 epitopes in women whose HPV16 infection has become undetectable.
Wang X; Moscicki AB; Tsang L; Brockman A; Nakagawa M
Clin Vaccine Immunol; 2008 Jun; 15(6):937-45. PubMed ID: 18448624
[TBL] [Abstract][Full Text] [Related]
14. HPV-16 E6 and E7 protein T cell epitopes prediction analysis based on distributions of HLA-A loci across populations: an in silico approach.
Yao Y; Huang W; Yang X; Sun W; Liu X; Cun W; Ma Y
Vaccine; 2013 Apr; 31(18):2289-94. PubMed ID: 23499609
[TBL] [Abstract][Full Text] [Related]
15. Mapping of cytotoxic T lymphocytes epitopes in E7 antigen of human papillomavirus type 11.
Xu Y; Zhu KJ; Chen XZ; Zhao KJ; Lu ZM; Cheng H
Arch Dermatol Res; 2008 Jun; 300(5):235-42. PubMed ID: 18299861
[TBL] [Abstract][Full Text] [Related]
16. Immunization with Human Papillomavirus 16 L1+E2 Chimeric Capsomers Elicits Cellular Immune Response and Antitumor Activity in a Mouse Model.
López-Toledo G; Schädlich L; Alonso-Castro ÁJ; Monroy-García A; García-Rocha R; Guido MC; Gissmann L; García-Carrancá A
Viral Immunol; 2016 Jun; 29(5):276-87. PubMed ID: 27058179
[TBL] [Abstract][Full Text] [Related]
17. Designing of multi-epitope chimeric vaccine using immunoinformatic platform by targeting oncogenic strain HPV 16 and 18 against cervical cancer.
Kumar A; Sahu U; Kumari P; Dixit A; Khare P
Sci Rep; 2022 Jun; 12(1):9521. PubMed ID: 35681036
[TBL] [Abstract][Full Text] [Related]
18. Identification of variants and therapeutic epitopes in HPV-33/HPV-58 E6 and E7 in Southwest China.
He J; Yang Y; Chen Z; Liu Y; Bao S; Zhao Y; Ding X
Virol J; 2019 May; 16(1):72. PubMed ID: 31138240
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics analysis of HPV-68 E6 and E7 oncoproteins for designing a therapeutic epitope vaccine against HPV infection.
Dong D; Zhu Y; Aili Z; Chen Z; Ding J
Infect Genet Evol; 2020 Jul; 81():104266. PubMed ID: 32114254
[TBL] [Abstract][Full Text] [Related]
20. Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis.
Jabbar B; Rafique S; Salo-Ahen OMH; Ali A; Munir M; Idrees M; Mirza MU; Vanmeert M; Shah SZ; Jabbar I; Rana MA
Front Immunol; 2018; 9():3000. PubMed ID: 30619353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
